U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C2H3AsO5.2Na
Molecular Weight 227.9434
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DISODIUM CARBOXYMETHYLARSONATE

SMILES

[Na+].[Na+].O[As]([O-])(=O)CC([O-])=O

InChI

InChIKey=DXAPLJQWRWMWHF-UHFFFAOYSA-L
InChI=1S/C2H5AsO5.2Na/c4-2(5)1-3(6,7)8;;/h1H2,(H,4,5)(H2,6,7,8);;/q;2*+1/p-2

HIDE SMILES / InChI

Molecular Formula C2H3AsO5
Molecular Weight 181.9638
Charge -2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Na
Molecular Weight 22.98976928
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including: Wilson, P.S. (2009) "Rediscovering Arsenoacetic Acid", p.9 Retrieved from http://researchcommons.waikato.ac.nz/bitstream/handle/10289/2778/thesis.pdf?sequence=1

Disodiurn salt of Arsonoacetic acid has been used in veterinary to treat anaplasmosis (babesiasis); as general stimulant in nervous disease; for eclampsia of bitches, and with adjuncts in chronic eczema and follicular mange. Arsonoacetic acid has not featured much in human medicine, a Chinese patent however, was filed in 2003 for arsonoacetic acid and its methyl or ethyl derivatives as chemotherapeutic drugs again liver cancer.

Originator

Sources: DOI: 10.1002/cber.191004301156

Approval Year

PubMed

PubMed

TitleDatePubMed
Tumor cell-specific prodrugs using arsonic acid-presenting iron oxide nanoparticles with high sensitivity.
2012-08-01
Arsonic acid-presenting superparamagnetic iron oxide for pH-responsive aggregation under slightly acidic conditions.
2011-04-01
The construction of a whole-cell biosensor for phosphonoacetate, based on the LysR-like transcriptional regulator PhnR from Pseudomonas fluorescens 23F.
2009-03
Carbon-arsenic bond cleavage by a newly isolated gram-negative bacterium, strain ASV2.
1995-03
The mechanism of pyrophosphorolysis of RNA by RNA polymerase. Endowment of RNA polymerase with artificial exonuclease activity.
1984-12-01
Mode of action of phosphonoformate as an anti-herpes simplex virus agent.
1981-01-29
Patents

Patents

Sample Use Guides

Horses, Cattle 10 ml Sheep, Goats 2-5 ml Big dogs 1.2 ml Dogs, Cats 0.2-0.5 ml Each ml contains 50 mg of disodium arsonoacetate.
Route of Administration: Other
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 22:15:53 GMT 2025
Edited
by admin
on Mon Mar 31 22:15:53 GMT 2025
Record UNII
T9HTL93NB7
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DISODIUM CARBOXYMETHYLARSONATE
Systematic Name English
ARSACTO
Preferred Name English
ACETIC ACID, ARSONO-, DISODIUM SALT
Common Name English
ARSONOACETIC ACID, DISODIUM SALT
Common Name English
ARSONOACETIC ACID,DISODIUM SALT
Common Name English
ARSONOACETIC ACID DISODIUM SALT
Common Name English
CARBOXYMETHYLARSONATE
Common Name English
ACETIC ACID, 2-ARSONO-, SODIUM SALT (1:2)
Systematic Name English
Code System Code Type Description
ECHA (EC/EINECS)
204-806-5
Created by admin on Mon Mar 31 22:15:53 GMT 2025 , Edited by admin on Mon Mar 31 22:15:53 GMT 2025
PRIMARY
EPA CompTox
DTXSID20155041
Created by admin on Mon Mar 31 22:15:53 GMT 2025 , Edited by admin on Mon Mar 31 22:15:53 GMT 2025
PRIMARY
FDA UNII
T9HTL93NB7
Created by admin on Mon Mar 31 22:15:53 GMT 2025 , Edited by admin on Mon Mar 31 22:15:53 GMT 2025
PRIMARY
DAILYMED
T9HTL93NB7
Created by admin on Mon Mar 31 22:15:53 GMT 2025 , Edited by admin on Mon Mar 31 22:15:53 GMT 2025
PRIMARY
RXCUI
1744168
Created by admin on Mon Mar 31 22:15:53 GMT 2025 , Edited by admin on Mon Mar 31 22:15:53 GMT 2025
ALTERNATIVE
CAS
126-82-9
Created by admin on Mon Mar 31 22:15:53 GMT 2025 , Edited by admin on Mon Mar 31 22:15:53 GMT 2025
PRIMARY
PUBCHEM
67177
Created by admin on Mon Mar 31 22:15:53 GMT 2025 , Edited by admin on Mon Mar 31 22:15:53 GMT 2025
PRIMARY
RXCUI
1744167
Created by admin on Mon Mar 31 22:15:53 GMT 2025 , Edited by admin on Mon Mar 31 22:15:53 GMT 2025
PRIMARY